This is a Validated Antibody Database (VAD) review about human ZEB1, based on 82 published articles (read how Labome selects the articles), using ZEB1 antibody in all methods. It is aimed to help Labome visitors find the most suited ZEB1 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
ZEB1 synonym: AREB6; BZP; DELTAEF1; FECD6; NIL2A; PPCD3; TCF8; ZFHEP; ZFHX1A

Knockout validation
MilliporeSigma
domestic rabbit polyclonal
  • immunocytochemistry knockout validation; mouse; loading ...; fig 2a
  • immunohistochemistry knockout validation; mouse; loading ...; fig 3a
  • western blot knockout validation; mouse; 1:5000; loading ...; fig 2c
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 3a
MilliporeSigma ZEB1 antibody (Sigma Prestige, HPA027524) was used in immunocytochemistry knockout validation on mouse samples (fig 2a), in immunohistochemistry knockout validation on mouse samples (fig 3a), in western blot knockout validation on mouse samples at 1:5000 (fig 2c) and in immunohistochemistry - paraffin section on mouse samples (fig 3a). Genesis (2017) ncbi
Abcam
mouse monoclonal (2A8A6)
  • immunocytochemistry; human; loading ...; fig a12s8b
Abcam ZEB1 antibody (Abcam, ab181451) was used in immunocytochemistry on human samples (fig a12s8b). J Exp Clin Cancer Res (2021) ncbi
domestic rabbit monoclonal (EPR17375)
  • western blot; human; 1:1000; loading ...; fig s3a
Abcam ZEB1 antibody (Abcam, ab203829) was used in western blot on human samples at 1:1000 (fig s3a). J Exp Clin Cancer Res (2021) ncbi
domestic rabbit monoclonal
  • western blot; human; loading ...; fig s1d
Abcam ZEB1 antibody (Abcam, ab228986) was used in western blot on human samples (fig s1d). BMC Cancer (2019) ncbi
domestic rabbit monoclonal (EPR17375)
  • western blot; human; loading ...; fig 2d
Abcam ZEB1 antibody (Abcam, ab203829) was used in western blot on human samples (fig 2d). Aging (Albany NY) (2019) ncbi
domestic rabbit monoclonal (EPR17375)
  • western blot; human; loading ...; fig 2b
Abcam ZEB1 antibody (Abcam, ab203829) was used in western blot on human samples (fig 2b). Theranostics (2019) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; mouse; 1:500; loading ...; fig e6e
Abcam ZEB1 antibody (Abcam, ab87280) was used in immunohistochemistry - paraffin section on mouse samples at 1:500 (fig e6e). Nature (2019) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 1i
Abcam ZEB1 antibody (Abcam, ab124512) was used in western blot on human samples (fig 1i). Biosci Rep (2017) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; human; 1:100; fig 3
Abcam ZEB1 antibody (Abcam, ab87280) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 3). PLoS ONE (2016) ncbi
  • western blot; human; 1:1000; fig 1
Abcam ZEB1 antibody (Abcam, ab81972) was used in western blot on human samples at 1:1000 (fig 1). PLoS ONE (2016) ncbi
OriGene
mouse monoclonal (OTI7E12)
  • western blot; human; 1:500; loading ...; fig 3a
In order to report how PTEN alters breast cancer metastatic behavior, OriGene ZEB1 antibody (OriGene Technologies, TA802313) was used in western blot on human samples at 1:500 (fig 3a). Anticancer Res (2016) ncbi
mouse monoclonal (OTI7E12)
  • western blot; human; 1:500; fig 5
In order to characterize attenuation of triple negative breast cancer cells metastatic potential by the vitamin D analog, MART-10, OriGene ZEB1 antibody (OriGene Technologies, TA802313) was used in western blot on human samples at 1:500 (fig 5). Int J Mol Sci (2016) ncbi
mouse monoclonal (OTI3G6)
  • western blot; human; 1:2000; tbl 4
OriGene ZEB1 antibody (Origene, TA802298) was used in western blot on human samples at 1:2000 (tbl 4). Sci Rep (2015) ncbi
Santa Cruz Biotechnology
mouse monoclonal (416A7H10)
  • western blot; human; 1:500; loading ...; fig 5b
Santa Cruz Biotechnology ZEB1 antibody (Santa Cruz, sc-81428) was used in western blot on human samples at 1:500 (fig 5b). Cancer Lett (2015) ncbi
mouse monoclonal (416A7H10)
  • western blot; human; 1:500
Santa Cruz Biotechnology ZEB1 antibody (Santa Cruz Biotechnology, sc-81428) was used in western blot on human samples at 1:500. Cell Death Dis (2014) ncbi
Novus Biologicals
domestic rabbit polyclonal (10C2)
  • western blot; human; 1:1000; loading ...; fig 1a
Novus Biologicals ZEB1 antibody (Novus Biologicals, NBP1-88845) was used in western blot on human samples at 1:1000 (fig 1a). Cell Death Dis (2019) ncbi
domestic rabbit polyclonal (10C2)
  • western blot; human; 1:1000; loading ...; fig s4a
Novus Biologicals ZEB1 antibody (Novus, NBP1-88845) was used in western blot on human samples at 1:1000 (fig s4a). Sci Rep (2019) ncbi
R&D Systems
mouse monoclonal (639914)
  • flow cytometry; human; loading ...; fig 1f
R&D Systems ZEB1 antibody (Bio-Techne, MAB6708) was used in flow cytometry on human samples (fig 1f). Cell (2018) ncbi
Invitrogen
mouse monoclonal (3G6)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig s4c
Invitrogen ZEB1 antibody (eBioscience, 14-9741-82) was used in immunohistochemistry - paraffin section on mouse samples (fig s4c). Cell (2019) ncbi
BioLegend
mouse monoclonal (P82A8A6)
  • western blot; human; 1:500; loading ...; fig 1d
BioLegend ZEB1 antibody (BioLegend, 685602) was used in western blot on human samples at 1:500 (fig 1d). Biochem Biophys Res Commun (2017) ncbi
Abnova
mouse monoclonal (4C4)
  • western blot; human; loading ...; fig 5b
Abnova ZEB1 antibody (Abnova, 4C4) was used in western blot on human samples (fig 5b). Mol Cell Biol (2017) ncbi
Cell Signaling Technology
domestic rabbit monoclonal (D80D3)
  • western blot; human; loading ...; fig 5b
Cell Signaling Technology ZEB1 antibody (Cell Signaling, 3396) was used in western blot on human samples (fig 5b). Transl Oncol (2022) ncbi
domestic rabbit monoclonal (D80D3)
  • western blot; human; fig 10c
Cell Signaling Technology ZEB1 antibody (CST, 3396) was used in western blot on human samples (fig 10c). Sci Adv (2021) ncbi
domestic rabbit monoclonal (D80D3)
  • western blot; human; loading ...; fig 6c, 6f
Cell Signaling Technology ZEB1 antibody (CST, 3396) was used in western blot on human samples (fig 6c, 6f). Mol Ther Nucleic Acids (2021) ncbi
domestic rabbit monoclonal (D80D3)
  • western blot; human; 1:1000; loading ...; fig 6b
Cell Signaling Technology ZEB1 antibody (Cell Signaling Technology, 3396) was used in western blot on human samples at 1:1000 (fig 6b). Commun Biol (2021) ncbi
domestic rabbit monoclonal (D80D3)
  • western blot; human; 1:1000; fig 3h
Cell Signaling Technology ZEB1 antibody (Cell Signaling, 3396) was used in western blot on human samples at 1:1000 (fig 3h). Commun Biol (2021) ncbi
domestic rabbit monoclonal (D80D3)
  • western blot; human; 1:1000; loading ...; fig 2g: 2h, 2i
Cell Signaling Technology ZEB1 antibody (CST, 3396) was used in western blot on human samples at 1:1000 (fig 2g: 2h, 2i). Am J Cancer Res (2020) ncbi
domestic rabbit monoclonal (D80D3)
  • western blot; human; loading ...; fig 5a
Cell Signaling Technology ZEB1 antibody (Cell Signaling Technology, 3396) was used in western blot on human samples (fig 5a). Oncogene (2020) ncbi
domestic rabbit monoclonal (D80D3)
  • western blot; human; 1:1000; loading ...; fig 4f
Cell Signaling Technology ZEB1 antibody (Cell Signaling Technology, 3396S) was used in western blot on human samples at 1:1000 (fig 4f). Cell Death Dis (2019) ncbi
domestic rabbit monoclonal (D80D3)
  • western blot; human; 1:1000; loading ...; fig 4b, s1b
Cell Signaling Technology ZEB1 antibody (CST, 3396S) was used in western blot on human samples at 1:1000 (fig 4b, s1b). Biol Open (2019) ncbi
domestic rabbit monoclonal (D80D3)
  • western blot; human; loading ...; fig 2a
Cell Signaling Technology ZEB1 antibody (CST, 3396) was used in western blot on human samples (fig 2a). Cell Commun Signal (2019) ncbi
domestic rabbit monoclonal (D80D3)
  • western blot; human; loading ...; fig 3d
Cell Signaling Technology ZEB1 antibody (CST, 3396) was used in western blot on human samples (fig 3d). J Exp Clin Cancer Res (2019) ncbi
domestic rabbit monoclonal (D80D3)
  • western blot; human; 1:1000; loading ...; fig 4c
Cell Signaling Technology ZEB1 antibody (Cell Signaling, 3396) was used in western blot on human samples at 1:1000 (fig 4c). BMC Cancer (2019) ncbi
domestic rabbit monoclonal (D80D3)
  • western blot; human; loading ...; fig 2a
Cell Signaling Technology ZEB1 antibody (Cell Signaling Technology, 3396) was used in western blot on human samples (fig 2a). elife (2019) ncbi
domestic rabbit monoclonal (D80D3)
  • western blot; human; 1:500; loading ...; fig s2a
Cell Signaling Technology ZEB1 antibody (Cell Signaling, 3396) was used in western blot on human samples at 1:500 (fig s2a). Sci Adv (2019) ncbi
domestic rabbit monoclonal (D80D3)
  • western blot; human; loading ...; fig 3b
Cell Signaling Technology ZEB1 antibody (Cell Signaling, 3396) was used in western blot on human samples (fig 3b). J Cell Mol Med (2018) ncbi
domestic rabbit monoclonal (D80D3)
  • western blot; human; 1:1000; fig s6i
Cell Signaling Technology ZEB1 antibody (Cell Signaling, 3396) was used in western blot on human samples at 1:1000 (fig s6i). Nat Commun (2017) ncbi
domestic rabbit monoclonal (D80D3)
  • western blot; human; 1:1000; loading ...; fig 7j
Cell Signaling Technology ZEB1 antibody (Cell Signaling, 3396) was used in western blot on human samples at 1:1000 (fig 7j). J Clin Invest (2017) ncbi
domestic rabbit monoclonal (D80D3)
  • western blot; human; 1:1000; loading ...; fig ex7b
Cell Signaling Technology ZEB1 antibody (Cell signaling, D80D3) was used in western blot on human samples at 1:1000 (fig ex7b). Nature (2017) ncbi
domestic rabbit monoclonal (D80D3)
  • western blot; human; loading ...; fig 2e
In order to investigate the effect off miR-509-5p and miR-1243 on gemcitabine efficacy in pancreatic cancer and its mechanism, Cell Signaling Technology ZEB1 antibody (Cell Signaling, 3396) was used in western blot on human samples (fig 2e). Sci Rep (2017) ncbi
domestic rabbit monoclonal (D80D3)
  • western blot; human; 1:1000; loading ...
In order to identify conditions in which low-passage ARPE-19 cells express genes specific to native human RPE cells, Cell Signaling Technology ZEB1 antibody (Cell Signaling, 3396) was used in western blot on human samples at 1:1000. Mol Vis (2017) ncbi
domestic rabbit monoclonal (D80D3)
  • immunocytochemistry; human; 1:100; fig 3b
In order to investigate how LACTB suppresses breast cancer cell growth, Cell Signaling Technology ZEB1 antibody (Cell Signaling, 3396) was used in immunocytochemistry on human samples at 1:100 (fig 3b). Nature (2017) ncbi
domestic rabbit monoclonal (D80D3)
  • western blot; human; 1:1000; loading ...; fig 6d
Cell Signaling Technology ZEB1 antibody (Cell Signaling, 3396) was used in western blot on human samples at 1:1000 (fig 6d). Int J Mol Med (2017) ncbi
domestic rabbit monoclonal (D80D3)
  • western blot; human; loading ...
Cell Signaling Technology ZEB1 antibody (Cell Signaling Technology, 3396) was used in western blot on human samples . Neoplasia (2017) ncbi
domestic rabbit monoclonal (D80D3)
  • western blot; human; loading ...; fig 7d
Cell Signaling Technology ZEB1 antibody (Cell Signalling, 3396) was used in western blot on human samples (fig 7d). Nucleic Acids Res (2016) ncbi
domestic rabbit monoclonal (D80D3)
  • immunohistochemistry; mouse; loading ...; fig 8l
Cell Signaling Technology ZEB1 antibody (Cell Signaling, 3396) was used in immunohistochemistry on mouse samples (fig 8l). Oncogene (2017) ncbi
domestic rabbit monoclonal (D80D3)
  • western blot; human; 1:1000; fig s3b
Cell Signaling Technology ZEB1 antibody (Cell Signaling, 3396) was used in western blot on human samples at 1:1000 (fig s3b). Science (2016) ncbi
domestic rabbit monoclonal (D80D3)
  • western blot; human; loading ...; fig 6a
Cell Signaling Technology ZEB1 antibody (Cell Signaling, 3396) was used in western blot on human samples (fig 6a). Sci Rep (2016) ncbi
domestic rabbit monoclonal (D80D3)
  • western blot; human; fig 5
Cell Signaling Technology ZEB1 antibody (Cell Signaling, 3396) was used in western blot on human samples (fig 5). Sci Rep (2016) ncbi
domestic rabbit monoclonal (D80D3)
  • western blot; human; 1:1000; fig 2
Cell Signaling Technology ZEB1 antibody (Cell Signaling, D80D3) was used in western blot on human samples at 1:1000 (fig 2). Sci Rep (2016) ncbi
domestic rabbit monoclonal (D80D3)
  • western blot; human; fig 6
Cell Signaling Technology ZEB1 antibody (Cell signaling, 3396) was used in western blot on human samples (fig 6). Oncotarget (2016) ncbi
domestic rabbit monoclonal (D80D3)
  • western blot; human; loading ...; fig 8b
Cell Signaling Technology ZEB1 antibody (Cell Signaling, 3396) was used in western blot on human samples (fig 8b). Nat Commun (2015) ncbi
domestic rabbit monoclonal (D80D3)
  • western blot; mouse; fig 1d
In order to test if ZO-1-mediated diminution of polarity results in an epithelial-to-mesenchyme transition and increased metastatic potential, Cell Signaling Technology ZEB1 antibody (Cell Signaling, 3396) was used in western blot on mouse samples (fig 1d). Oncogene (2016) ncbi
domestic rabbit monoclonal (D80D3)
  • western blot; human; fig 7a
In order to demonstrate that LRIG1 functions as a growth suppressor in breast cancer cells, Cell Signaling Technology ZEB1 antibody (Cell Signaling Technology, 3396) was used in western blot on human samples (fig 7a). Oncogene (2016) ncbi
domestic rabbit monoclonal (D80D3)
  • western blot; human; 1:1000; fig 5
Cell Signaling Technology ZEB1 antibody (Cell Signaling, D80D3) was used in western blot on human samples at 1:1000 (fig 5). Nucleic Acids Res (2015) ncbi
domestic rabbit monoclonal (D80D3)
  • western blot; human; 1:1000; fig 2
Cell Signaling Technology ZEB1 antibody (Cell signaling, 3396) was used in western blot on human samples at 1:1000 (fig 2). Oncotarget (2015) ncbi
domestic rabbit monoclonal (D80D3)
  • other; human; loading ...; fig 4a, 4d
Cell Signaling Technology ZEB1 antibody (Cell Signaling, 3396) was used in other on human samples (fig 4a, 4d). PLoS ONE (2015) ncbi
domestic rabbit monoclonal (D80D3)
  • western blot; human; fig 3
Cell Signaling Technology ZEB1 antibody (Cell Signaling Technology, 3396) was used in western blot on human samples (fig 3). Sci Rep (2015) ncbi
domestic rabbit monoclonal (D80D3)
  • immunohistochemistry - paraffin section; mouse
  • western blot; mouse
In order to investigate the effect of miR-200c on claudin-low breast cancer, Cell Signaling Technology ZEB1 antibody (Cell Signaling, 3396) was used in immunohistochemistry - paraffin section on mouse samples and in western blot on mouse samples . Oncogene (2015) ncbi
domestic rabbit monoclonal (D80D3)
  • western blot; human; fig 3
In order to elucidate the tumor suppressor function of BTG3, Cell Signaling Technology ZEB1 antibody (Cell Signaling Technologies, 3396) was used in western blot on human samples (fig 3). Cell Death Dis (2015) ncbi
domestic rabbit monoclonal (D80D3)
  • immunocytochemistry; human
Cell Signaling Technology ZEB1 antibody (Cell Signaling, 3396) was used in immunocytochemistry on human samples . PLoS ONE (2014) ncbi
domestic rabbit monoclonal (D80D3)
  • western blot; human; fig 3
In order to investigate the roles and mechanisms of the RSPO-LGR system in oncogenesis, Cell Signaling Technology ZEB1 antibody (Cell Signaling Technology, 3396) was used in western blot on human samples (fig 3). Oncogene (2015) ncbi
domestic rabbit monoclonal (D80D3)
  • western blot; human; fig 1
Cell Signaling Technology ZEB1 antibody (Cell signaling, 3396) was used in western blot on human samples (fig 1). Oncotarget (2015) ncbi
domestic rabbit monoclonal (D80D3)
  • western blot; human
In order to study how phosphorylation alters COP1-binding sites of oncoproteins, Cell Signaling Technology ZEB1 antibody (Cell Signaling, 3396) was used in western blot on human samples . Cancer Cell (2014) ncbi
domestic rabbit monoclonal (D80D3)
  • western blot; human
Cell Signaling Technology ZEB1 antibody (Cell Signaling Technology, 3396) was used in western blot on human samples . PLoS ONE (2014) ncbi
domestic rabbit monoclonal (D80D3)
  • western blot; mouse; fig 2e
In order to show that Basonuclin-1 regulates TGF-beta1-induced epithelial dedifferentiation of mammary epithelial cells, Cell Signaling Technology ZEB1 antibody (Cell Signaling Technologies, 3396) was used in western blot on mouse samples (fig 2e). Oncogene (2015) ncbi
domestic rabbit monoclonal (D80D3)
  • western blot; human
Cell Signaling Technology ZEB1 antibody (Cell Signaling, 3396p) was used in western blot on human samples . Cancer Res (2014) ncbi
domestic rabbit monoclonal (D80D3)
  • western blot; human
Cell Signaling Technology ZEB1 antibody (Cell Signaling, 3396S) was used in western blot on human samples . PLoS ONE (2013) ncbi
Genway Biotech
mouse monoclonal (416A7H10)
  • immunohistochemistry; human; 1:20; fig 1
In order to investigate the contribution of ZEB1 in intrahepatic cholangiocarcinoma, Genway Biotech ZEB1 antibody (Genway Biotech, GWB-B65B99) was used in immunohistochemistry on human samples at 1:20 (fig 1). J Clin Pathol (2016) ncbi
mouse monoclonal (416A7H10)
  • immunohistochemistry - paraffin section; human; 1:500; loading ...; fig 3a
In order to evaluate the impact of claudin expression in grade I-III ependymomas, Genway Biotech ZEB1 antibody (GenWay, 416A7H10) was used in immunohistochemistry - paraffin section on human samples at 1:500 (fig 3a). Histol Histopathol (2013) ncbi
MilliporeSigma
domestic rabbit polyclonal
  • western blot; human; 1:500; loading ...; fig 2b
MilliporeSigma ZEB1 antibody (Sigma-Aldrich, HPA027524) was used in western blot on human samples at 1:500 (fig 2b). NPJ Breast Cancer (2021) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:2000; loading ...; fig 4a, 4b, 4c
MilliporeSigma ZEB1 antibody (Sigma-Aldrich, HPA027524) was used in western blot on human samples at 1:2000 (fig 4a, 4b, 4c). Oncogene (2019) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 4a
MilliporeSigma ZEB1 antibody (Sigma, HPA027524) was used in western blot on human samples (fig 4a). Cancer Res (2018) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; fig 6c
  • western blot; human; loading ...; fig 1g
In order to investigate the relationship between thymidylate synthase and epithelial-to-mesenchymal transition, MilliporeSigma ZEB1 antibody (Sigma, HPA027524) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 6c) and in western blot on human samples (fig 1g). J Pathol (2017) ncbi
domestic rabbit polyclonal
  • immunocytochemistry knockout validation; mouse; loading ...; fig 2a
  • immunohistochemistry knockout validation; mouse; loading ...; fig 3a
  • western blot knockout validation; mouse; 1:5000; loading ...; fig 2c
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 3a
MilliporeSigma ZEB1 antibody (Sigma Prestige, HPA027524) was used in immunocytochemistry knockout validation on mouse samples (fig 2a), in immunohistochemistry knockout validation on mouse samples (fig 3a), in western blot knockout validation on mouse samples at 1:5000 (fig 2c) and in immunohistochemistry - paraffin section on mouse samples (fig 3a). Genesis (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 1b
MilliporeSigma ZEB1 antibody (Sigma, HPA027524) was used in western blot on human samples (fig 1b). Oncotarget (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; human; 1:400; fig 2
MilliporeSigma ZEB1 antibody (Sigma, HPA027524) was used in immunohistochemistry - paraffin section on human samples at 1:400 (fig 2). EMBO Mol Med (2016) ncbi
domestic rabbit polyclonal
  • immunocytochemistry; human; 1:1000; loading ...; fig 5
In order to discuss mechanisms of mTOR-I-associated pulmonary toxicity, MilliporeSigma ZEB1 antibody (Sigma, HPA027524) was used in immunocytochemistry on human samples at 1:1000 (fig 5). J Nephrol (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:5000; fig 2
In order to study the interaction with YAP1 in aggressive cancer types by ZEB1 turning into a transcriptional activator, MilliporeSigma ZEB1 antibody (Sigma, HPA027524) was used in western blot on human samples at 1:5000 (fig 2). Nat Commun (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; human; 1:800; loading ...; fig 1a
In order to characterize circulating tumor cells and determine prognostic markers for pancreatic ductal adenocarcinoma, MilliporeSigma ZEB1 antibody (Sigma, HPA027524) was used in immunohistochemistry on human samples at 1:800 (fig 1a). Tumour Biol (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; human; fig 4
  • western blot; human; fig 1c
In order to elucidate the contribution of SPRY2 to colon cancer, MilliporeSigma ZEB1 antibody (Sigma-Aldrich, HPA027524) was used in immunohistochemistry on human samples (fig 4) and in western blot on human samples (fig 1c). Oncogene (2016) ncbi
domestic rabbit polyclonal
MilliporeSigma ZEB1 antibody (Sigma Prestige, HPA027524) was used . Int J Cancer (2015) ncbi
domestic rabbit polyclonal
MilliporeSigma ZEB1 antibody (Sigma, HPA027524) was used . EMBO Mol Med (2015) ncbi
ProSci
domestic rabbit polyclonal
  • western blot; human; 1:250; fig 5
In order to research induction of epithelial-to-mesenchymal transition by Polo-like kinase 1 and promotion of epithelial cell motility by activating CRAF/ERK signaling, ProSci ZEB1 antibody (ProSci Inc, 5825) was used in western blot on human samples at 1:250 (fig 5). elife (2016) ncbi
Articles Reviewed
  1. Yang J, Liao Q, Price M, Moriarity B, Wolf N, Felices M, et al. Chondroitin sulfate proteoglycan 4, a targetable oncoantigen that promotes ovarian cancer growth, invasion, cisplatin resistance and spheroid formation. Transl Oncol. 2022;16:101318 pubmed publisher
  2. Li K, Wu R, Zhou M, Tong H, Luo K. Desmosomal proteins of DSC2 and PKP1 promote cancer cells survival and metastasis by increasing cluster formation in circulatory system. Sci Adv. 2021;7:eabg7265 pubmed publisher
  3. Gyamfi J, Yeo J, Kwon D, Min B, Cha Y, Koo J, et al. Interaction between CD36 and FABP4 modulates adipocyte-induced fatty acid import and metabolism in breast cancer. NPJ Breast Cancer. 2021;7:129 pubmed publisher
  4. Sun Z, Sun D, Feng Y, Zhang B, Sun P, Zhou B, et al. Exosomal linc-ROR mediates crosstalk between cancer cells and adipocytes to promote tumor growth in pancreatic cancer. Mol Ther Nucleic Acids. 2021;26:253-268 pubmed publisher
  5. Wang X, Li X, Lin F, Sun H, Lin Y, Wang Z, et al. The lnc-CTSLP8 upregulates CTSL1 as a competitive endogenous RNA and promotes ovarian cancer metastasis. J Exp Clin Cancer Res. 2021;40:151 pubmed publisher
  6. Kariya Y, Oyama M, Suzuki T, Kariya Y. αvβ3 Integrin induces partial EMT independent of TGF-β signaling. Commun Biol. 2021;4:490 pubmed publisher
  7. Hu X, Villodre E, Larson R, Rahal O, Wang X, Gong Y, et al. Decorin-mediated suppression of tumorigenesis, invasion, and metastasis in inflammatory breast cancer. Commun Biol. 2021;4:72 pubmed publisher
  8. Jiang Y, Han Q, Zhao H, Zhang J. Promotion of epithelial-mesenchymal transformation by hepatocellular carcinoma-educated macrophages through Wnt2b/β-catenin/c-Myc signaling and reprogramming glycolysis. J Exp Clin Cancer Res. 2021;40:13 pubmed publisher
  9. Li M, Wu P, Yang Z, Deng S, Ni L, Zhang Y, et al. miR-193a-5p promotes pancreatic cancer cell metastasis through SRSF6-mediated alternative splicing of OGDHL and ECM1. Am J Cancer Res. 2020;10:38-59 pubmed
  10. Hu Y, Ma Y, Liu J, Cai Y, Zhang M, Fang X. LINC01128 expedites cervical cancer progression by regulating miR-383-5p/SFN axis. BMC Cancer. 2019;19:1157 pubmed publisher
  11. Chen X, Xiong X, Cui D, Yang F, Wei D, Li H, et al. DEPTOR is an in vivo tumor suppressor that inhibits prostate tumorigenesis via the inactivation of mTORC1/2 signals. Oncogene. 2020;39:1557-1571 pubmed publisher
  12. Tan P, Xu Y, Du Y, Wu L, Guo B, Huang S, et al. SPOP suppresses pancreatic cancer progression by promoting the degradation of NANOG. Cell Death Dis. 2019;10:794 pubmed publisher
  13. Tian M, Gong W, Guo J. Long non-coding RNA SNHG1 indicates poor prognosis and facilitates disease progression in acute myeloid leukemia. Biol Open. 2019;8: pubmed publisher
  14. Bi J, Yang S, Li L, Dai Q, Borcherding N, Wagner B, et al. Metadherin enhances vulnerability of cancer cells to ferroptosis. Cell Death Dis. 2019;10:682 pubmed publisher
  15. Jiang S, Zhang M, Zhang Y, Zhou W, Zhu T, Ruan Q, et al. WNT5B governs the phenotype of basal-like breast cancer by activating WNT signaling. Cell Commun Signal. 2019;17:109 pubmed publisher
  16. Wei C, Zhu M, Zhang P, Yang X, Wang L, Ying J, et al. Elevated kindlin-2 promotes tumour progression and angiogenesis through the mTOR/VEGFA pathway in melanoma. Aging (Albany NY). 2019;11:6273-6285 pubmed publisher
  17. Li Q, Lai Q, He C, Fang Y, Yan Q, Zhang Y, et al. RUNX1 promotes tumour metastasis by activating the Wnt/β-catenin signalling pathway and EMT in colorectal cancer. J Exp Clin Cancer Res. 2019;38:334 pubmed publisher
  18. Du F, Qiao C, Li X, Chen Z, Liu H, Wu S, et al. Forkhead box K2 promotes human colorectal cancer metastasis by upregulating ZEB1 and EGFR. Theranostics. 2019;9:3879-3902 pubmed publisher
  19. Smestad J, Maher L. Master regulator analysis of paragangliomas carrying SDHx, VHL, or MAML3 genetic alterations. BMC Cancer. 2019;19:619 pubmed publisher
  20. Adams C, Htwe H, Marsh T, Wang A, Montoya M, Subbaraj L, et al. Transcriptional control of subtype switching ensures adaptation and growth of pancreatic cancer. elife. 2019;8: pubmed publisher
  21. Sonego M, Pellarin I, Costa A, Vinciguerra G, Coan M, Kraut A, et al. USP1 links platinum resistance to cancer cell dissemination by regulating Snail stability. Sci Adv. 2019;5:eaav3235 pubmed publisher
  22. Shi Y, Gao W, Lytle N, Huang P, Yuan X, Dann A, et al. Targeting LIF-mediated paracrine interaction for pancreatic cancer therapy and monitoring. Nature. 2019;569:131-135 pubmed publisher
  23. Vanneste M, Huang Q, Li M, Moose D, Zhao L, STAMNES M, et al. High content screening identifies monensin as an EMT-selective cytotoxic compound. Sci Rep. 2019;9:1200 pubmed publisher
  24. Sharon N, Chawla R, Mueller J, Vanderhooft J, Whitehorn L, Rosenthal B, et al. A Peninsular Structure Coordinates Asynchronous Differentiation with Morphogenesis to Generate Pancreatic Islets. Cell. 2019;176:790-804.e13 pubmed publisher
  25. Asnaghi L, White D, Key N, Choi J, Mahale A, Alkatan H, et al. ACVR1C/SMAD2 signaling promotes invasion and growth in retinoblastoma. Oncogene. 2019;38:2056-2075 pubmed publisher
  26. Kinchen J, Chen H, Parikh K, Antanaviciute A, Jagielowicz M, Fawkner Corbett D, et al. Structural Remodeling of the Human Colonic Mesenchyme in Inflammatory Bowel Disease. Cell. 2018;175:372-386.e17 pubmed publisher
  27. Vl kov K, Vachtenheim J, R da J, Hor k P, Ondru ov L. Inducibly decreased MITF levels do not affect proliferation and phenotype switching but reduce differentiation of melanoma cells. J Cell Mol Med. 2018;22:2240-2251 pubmed publisher
  28. Wang J, Ye Q, Cao Y, Guo Y, Huang X, Mi W, et al. Snail determines the therapeutic response to mTOR kinase inhibitors by transcriptional repression of 4E-BP1. Nat Commun. 2017;8:2207 pubmed publisher
  29. Yu R, Longo J, van Leeuwen J, Mullen P, Ba Alawi W, Haibe Kains B, et al. Statin-Induced Cancer Cell Death Can Be Mechanistically Uncoupled from Prenylation of RAS Family Proteins. Cancer Res. 2018;78:1347-1357 pubmed publisher
  30. Caino M, Seo J, Wang Y, Rivadeneira D, Gabrilovich D, Kim E, et al. Syntaphilin controls a mitochondrial rheostat for proliferation-motility decisions in cancer. J Clin Invest. 2017;127:3755-3769 pubmed publisher
  31. Ma X, Li L, Jia T, Chen M, Liu G, Li C, et al. miR-203a controls keratinocyte proliferation and differentiation via targeting the stemness-associated factor ?Np63 and establishing a regulatory circuit with SNAI2. Biochem Biophys Res Commun. 2017;491:241-249 pubmed publisher
  32. Viswanathan V, Ryan M, Dhruv H, Gill S, Eichhoff O, Seashore Ludlow B, et al. Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway. Nature. 2017;547:453-457 pubmed publisher
  33. Hiramoto H, Muramatsu T, Ichikawa D, Tanimoto K, Yasukawa S, Otsuji E, et al. miR-509-5p and miR-1243 increase the sensitivity to gemcitabine by inhibiting epithelial-mesenchymal transition in pancreatic cancer. Sci Rep. 2017;7:4002 pubmed publisher
  34. Al Khalaf H, Amir M, Al Mohanna F, Tulbah A, Al Sayed A, Aboussekhra A. Obesity and p16INK4A Downregulation Activate Breast Adipocytes and Promote Their Protumorigenicity. Mol Cell Biol. 2017;37: pubmed publisher
  35. Samuel W, Jaworski C, Postnikova O, Kutty R, Duncan T, Tan L, et al. Appropriately differentiated ARPE-19 cells regain phenotype and gene expression profiles similar to those of native RPE cells. Mol Vis. 2017;23:60-89 pubmed
  36. Siddiqui A, Vazakidou M, Schwab A, Napoli F, Fernandez Molina C, Rapa I, et al. Thymidylate synthase is functionally associated with ZEB1 and contributes to the epithelial-to-mesenchymal transition of cancer cells. J Pathol. 2017;242:221-233 pubmed publisher
  37. Keckesova Z, Donaher J, De Cock J, Freinkman E, Lingrell S, Bachovchin D, et al. LACTB is a tumour suppressor that modulates lipid metabolism and cell state. Nature. 2017;543:681-686 pubmed publisher
  38. Li X, Liu W, Chen X, Wang Y, Shi D, Zhang H, et al. Overexpression of TMPRSS4 promotes tumor proliferation and aggressiveness in breast cancer. Int J Mol Med. 2017;39:927-935 pubmed publisher
  39. Zhang L, Liu H, Mu X, Cui J, Peng Z. Dysregulation of Fra1 expression by Wnt/β-catenin signalling promotes glioma aggressiveness through epithelial-mesenchymal transition. Biosci Rep. 2017;37: pubmed publisher
  40. Brabletz S, Lasierra Losada M, Schmalhofer O, Mitschke J, Krebs A, Brabletz T, et al. Generation and characterization of mice for conditional inactivation of Zeb1. Genesis. 2017;55: pubmed publisher
  41. Zhai S, Liu C, Zhang L, Zhu J, Guo J, Zhang J, et al. PLCE1 Promotes Esophageal Cancer Cell Progression by Maintaining the Transcriptional Activity of Snail. Neoplasia. 2017;19:154-164 pubmed publisher
  42. Fletcher C, Godfrey J, Shibakawa A, Bushell M, Bevan C. A novel role for GSK3? as a modulator of Drosha microprocessor activity and MicroRNA biogenesis. Nucleic Acids Res. 2016;: pubmed
  43. Koch K, Hartmann R, Schröter F, Suwala A, Maciaczyk D, Krüger A, et al. Reciprocal regulation of the cholinic phenotype and epithelial-mesenchymal transition in glioblastoma cells. Oncotarget. 2016;7:73414-73431 pubmed publisher
  44. Chiang K, Hsu S, Lin S, Yeh C, Pang J, Wang S, et al. PTEN Insufficiency Increases Breast Cancer Cell Metastasis In Vitro and In Vivo in a Xenograft Zebrafish Model. Anticancer Res. 2016;36:3997-4005 pubmed
  45. Zhang Q, Liu S, Parajuli K, Zhang W, Zhang K, Mo Z, et al. Interleukin-17 promotes prostate cancer via MMP7-induced epithelial-to-mesenchymal transition. Oncogene. 2017;36:687-699 pubmed publisher
  46. Fessler E, Drost J, van Hooff S, Linnekamp J, Wang X, Jansen M, et al. TGFβ signaling directs serrated adenomas to the mesenchymal colorectal cancer subtype. EMBO Mol Med. 2016;8:745-60 pubmed publisher
  47. Chiang K, Yeh T, Chen S, Pang J, Yeh C, Hsu J, et al. The Vitamin D Analog, MART-10, Attenuates Triple Negative Breast Cancer Cells Metastatic Potential. Int J Mol Sci. 2016;17: pubmed publisher
  48. Tomei P, Masola V, Granata S, Bellin G, Carratu P, Ficial M, et al. Everolimus-induced epithelial to mesenchymal transition (EMT) in bronchial/pulmonary cells: when the dosage does matter in transplantation. J Nephrol. 2016;29:881-891 pubmed
  49. Wu J, Ivanov A, Fisher P, Fu Z. Polo-like kinase 1 induces epithelial-to-mesenchymal transition and promotes epithelial cell motility by activating CRAF/ERK signaling. elife. 2016;5: pubmed publisher
  50. Pattabiraman D, Bierie B, Kober K, Thiru P, Krall J, Zill C, et al. Activation of PKA leads to mesenchymal-to-epithelial transition and loss of tumor-initiating ability. Science. 2016;351:aad3680 pubmed publisher
  51. Chung V, Tan T, Tan M, Wong M, Kuay K, Yang Z, et al. GRHL2-miR-200-ZEB1 maintains the epithelial status of ovarian cancer through transcriptional regulation and histone modification. Sci Rep. 2016;6:19943 pubmed publisher
  52. Haraguchi T, Kondo M, Uchikawa R, Kobayashi K, Hiramatsu H, Kobayashi K, et al. Dynamics and plasticity of the epithelial to mesenchymal transition induced by miR-200 family inhibition. Sci Rep. 2016;6:21117 pubmed publisher
  53. Liu L, Tong Q, Liu S, Cui J, Zhang Q, Sun W, et al. ZEB1 Upregulates VEGF Expression and Stimulates Angiogenesis in Breast Cancer. PLoS ONE. 2016;11:e0148774 pubmed publisher
  54. Lehmann W, Mossmann D, Kleemann J, Mock K, Meisinger C, Brummer T, et al. ZEB1 turns into a transcriptional activator by interacting with YAP1 in aggressive cancer types. Nat Commun. 2016;7:10498 pubmed publisher
  55. Fazio C, Piazzi G, Vitaglione P, Fogliano V, Munarini A, Prossomariti A, et al. Inflammation increases NOTCH1 activity via MMP9 and is counteracted by Eicosapentaenoic Acid-free fatty acid in colon cancer cells. Sci Rep. 2016;6:20670 pubmed publisher
  56. Wang F, Feng Y, Li P, Wang K, Feng L, Liu Y, et al. RASSF10 is an epigenetically inactivated tumor suppressor and independent prognostic factor in hepatocellular carcinoma. Oncotarget. 2016;7:4279-97 pubmed publisher
  57. Kulemann B, Liss A, Warshaw A, Seifert S, Bronsert P, Glatz T, et al. KRAS mutations in pancreatic circulating tumor cells: a pilot study. Tumour Biol. 2016;37:7547-54 pubmed publisher
  58. Terashita K, Chuma M, Hatanaka Y, Hatanaka K, Mitsuhashi T, Yokoo H, et al. ZEB1 expression is associated with prognosis of intrahepatic cholangiocarcinoma. J Clin Pathol. 2016;69:593-9 pubmed publisher
  59. Chen C, Zhu C, Huang J, Zhao X, Deng R, Zhang H, et al. SUMOylation of TARBP2 regulates miRNA/siRNA efficiency. Nat Commun. 2015;6:8899 pubmed publisher
  60. Barbáchano A, Fernández Barral A, Pereira F, Segura M, Ordóñez Morán P, Carrillo de Santa Pau E, et al. SPROUTY-2 represses the epithelial phenotype of colon carcinoma cells via upregulation of ZEB1 mediated by ETS1 and miR-200/miR-150. Oncogene. 2016;35:2991-3003 pubmed publisher
  61. Nath A, Li I, Roberts L, Chan C. Elevated free fatty acid uptake via CD36 promotes epithelial-mesenchymal transition in hepatocellular carcinoma. Sci Rep. 2015;5:14752 pubmed publisher
  62. Nagaoka K, Fujii K, Zhang H, Usuda K, Watanabe G, Ivshina M, et al. CPEB1 mediates epithelial-to-mesenchyme transition and breast cancer metastasis. Oncogene. 2016;35:2893-901 pubmed publisher
  63. Yokdang N, Hatakeyama J, Wald J, Simion C, Tellez J, Chang D, et al. LRIG1 opposes epithelial-to-mesenchymal transition and inhibits invasion of basal-like breast cancer cells. Oncogene. 2016;35:2932-47 pubmed publisher
  64. Zhu C, Chen C, Huang J, Zhang H, Zhao X, Deng R, et al. SUMOylation at K707 of DGCR8 controls direct function of primary microRNA. Nucleic Acids Res. 2015;43:7945-60 pubmed publisher
  65. Preca B, Bajdak K, Mock K, Sundararajan V, Pfannstiel J, Maurer J, et al. A self-enforcing CD44s/ZEB1 feedback loop maintains EMT and stemness properties in cancer cells. Int J Cancer. 2015;137:2566-77 pubmed publisher
  66. Zucha M, Wu A, Lee W, Wang L, Lin W, Yuan C, et al. Bruton's tyrosine kinase (Btk) inhibitor ibrutinib suppresses stem-like traits in ovarian cancer. Oncotarget. 2015;6:13255-68 pubmed
  67. Meidhof S, Brabletz S, Lehmann W, Preca B, Mock K, Ruh M, et al. ZEB1-associated drug resistance in cancer cells is reversed by the class I HDAC inhibitor mocetinostat. EMBO Mol Med. 2015;7:831-47 pubmed publisher
  68. Yamada A, Aki T, Unuma K, Funakoshi T, Uemura K. Paraquat induces epithelial-mesenchymal transition-like cellular response resulting in fibrogenesis and the prevention of apoptosis in human pulmonary epithelial cells. PLoS ONE. 2015;10:e0120192 pubmed publisher
  69. Lin Y, Yang Z, Xu A, Dong P, Huang Y, Liu H, et al. PIK3R1 negatively regulates the epithelial-mesenchymal transition and stem-like phenotype of renal cancer cells through the AKT/GSK3β/CTNNB1 signaling pathway. Sci Rep. 2015;5:8997 pubmed publisher
  70. Knezevic J, Pfefferle A, Petrovic I, Greene S, Perou C, Rosen J. Expression of miR-200c in claudin-low breast cancer alters stem cell functionality, enhances chemosensitivity and reduces metastatic potential. Oncogene. 2015;34:5997-6006 pubmed publisher
  71. Joseph J, Conroy S, Pavlov K, Sontakke P, Tomar T, Eggens Meijer E, et al. Hypoxia enhances migration and invasion in glioblastoma by promoting a mesenchymal shift mediated by the HIF1α-ZEB1 axis. Cancer Lett. 2015;359:107-16 pubmed publisher
  72. Cheng Y, Chen P, Chiang H, Suen C, Hwang M, Lin T, et al. Candidate tumor suppressor B-cell translocation gene 3 impedes neoplastic progression by suppression of AKT. Cell Death Dis. 2015;6:e1584 pubmed publisher
  73. Tange S, Oktyabri D, Terashima M, Ishimura A, Suzuki T. JARID2 is involved in transforming growth factor-beta-induced epithelial-mesenchymal transition of lung and colon cancer cell lines. PLoS ONE. 2014;9:e115684 pubmed publisher
  74. Gong X, Yi J, Carmon K, Crumbley C, Xiong W, Thomas A, et al. Aberrant RSPO3-LGR4 signaling in Keap1-deficient lung adenocarcinomas promotes tumor aggressiveness. Oncogene. 2015;34:4692-701 pubmed publisher
  75. Xu M, Zhu C, Zhao X, Chen C, Zhang H, Yuan H, et al. Atypical ubiquitin E3 ligase complex Skp1-Pam-Fbxo45 controls the core epithelial-to-mesenchymal transition-inducing transcription factors. Oncotarget. 2015;6:979-94 pubmed
  76. Joseph J, Conroy S, Tomar T, Eggens Meijer E, Bhat K, Copray S, et al. TGF-β is an inducer of ZEB1-dependent mesenchymal transdifferentiation in glioblastoma that is associated with tumor invasion. Cell Death Dis. 2014;5:e1443 pubmed publisher
  77. Lu G, Zhang Q, Huang Y, Song J, Tomaino R, Ehrenberger T, et al. Phosphorylation of ETS1 by Src family kinases prevents its recognition by the COP1 tumor suppressor. Cancer Cell. 2014;26:222-34 pubmed publisher
  78. Subramani R, Lopez Valdez R, Arumugam A, Nandy S, Boopalan T, Lakshmanaswamy R. Targeting insulin-like growth factor 1 receptor inhibits pancreatic cancer growth and metastasis. PLoS ONE. 2014;9:e97016 pubmed publisher
  79. Feuerborn A, Mathow D, Srivastava P, Gretz N, Grone H. Basonuclin-1 modulates epithelial plasticity and TGF-?1-induced loss of epithelial cell integrity. Oncogene. 2015;34:1185-95 pubmed publisher
  80. Wu K, Chen K, Wang C, Jiao X, Wang L, Zhou J, et al. Cell fate factor DACH1 represses YB-1-mediated oncogenic transcription and translation. Cancer Res. 2014;74:829-39 pubmed publisher
  81. Harazono Y, Muramatsu T, Endo H, Uzawa N, Kawano T, Harada K, et al. miR-655 Is an EMT-suppressive microRNA targeting ZEB1 and TGFBR2. PLoS ONE. 2013;8:e62757 pubmed publisher
  82. Nordfors K, Haapasalo J, Sallinen P, Haapasalo H, Soini Y. Expression of claudins relates to tumour aggressivity, location and recurrence in ependymomas. Histol Histopathol. 2013;28:1137-46 pubmed publisher